In heterogeneous catalysis, the catalyst is in a different phase from the reactants. COA of Formula: C8H4BrFN2, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1210048-05-7, name is 7-Bromo-5-fluoroquinoxaline. In an article，Which mentioned a new discovery about 1210048-05-7
FUSED PYRAZINE DERIVATIVES AS KINASE INHIBITORS
A series of quinoxaline derivatives, and analogues thereof, which are functionalised further by a substituted phenyl or pyridinyl moiety, being selective inhibitors of PO kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1210048-05-7, help many people in the next few years.COA of Formula: C8H4BrFN2
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1820 | ChemSpider